Liquid biopsy in H3K27M diffuse midline glioma is a research paper published in Neuro-Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01-NS119231
National Institutes of Health
Grant: R01-NS124607
DOD
Grant: CA201129P1
National Institutes of Health
Grant: 5R01NS124607-03
Targeting EGFR/FOXG1-mediated resistance to ONC201 in H3K27M-mutant diffuse midline glioma
National Institutes of Health
Grant: 5R01NS119231-04
The role of ATRX mutation in the epigenetic dysregulation of cell cycle in pediatric high-grade glioma
NHLBI NIH HHS
Grant: T32 HL007622
NHLBI NIH HHS
Grant: T32 HL007749
NINDS NIH HHS
Grant: R01 NS124607
NINDS NIH HHS
Grant: R01 NS119231
FWCI
4.51
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals